SCHEMBL1766102

SCHEMBL1766102

CCC(=O)C1C(=O)CC(c2ccccc2)CC1=O

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
GAA P10253 2/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
LMNA P02545 1/20 0.43
AKR1C3 P42330 1/20 0.42
AKR1C1 Q04828 1/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAP1LC3B Q9GZQ8 1/20 0.41
BRD4 O60885 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10359523 0.91 ALDH1A1 (0.39) MAPTGAARAB9AALDH1A1MEN1
SCHEMBL10360042 0.90 RAB9A (0.38) MAPTGAARAB9AALDH1A1
SCHEMBL22111686 0.86 MAPT (0.47) MAPTGAARAB9AALDH1A1HPGD
SCHEMBL11161272 0.83 ALDH1A1 (0.46) MAPTGAAALDH1A1HPGDAKR1C1
SCHEMBL12648133 0.83 MAP1LC3B (0.44) LMNAPOLBMAP1LC3B
SCHEMBL11170815 0.82 MAPT (0.50) MAPTGAAALDH1A1HPGDMEN1
SCHEMBL12648266 0.81 ALDH1A1 (0.46) MAPTGAARAB9AALDH1A1HPGD
SCHEMBL12648386 0.81 MAPT (0.53) MAPTGAARAB9AALDH1A1HPGD
SCHEMBL11163428 0.81 GAA (0.47) MAPTGAAALDH1A1HPGDAKR1C1
SCHEMBL11164822 0.81 SMN1; SMN2 (0.45) MAPTGAARAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
EP-2501229-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS University Of Rochester (US) 2012-09-26 EP disclosed
WO-2011062964-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS UNIVERSITY OF ROCHESTER (US) 2011-05-26 WO disclosed
EP-0202042-B1 CYCLOHEXANE-1,3-DIONE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PROCESSES FOR PREPARING THEM, AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS ICI AUSTRALIA LIMITED (AU) 1990-05-09 EP disclosed
US-4746350-A Herbicidal bis(cyclohexane-1,3-dione)derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms HDAC5, AADAC, SIRT1 MAPT 2167/4885GAA 1628/4885RAB9A 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.